It is likely that the babies' symptoms were mainly due to the caustic action of cetrimide 1%2 3; fortunately contact with the mixture was necessarily very brief as it is irritant with an unpleasant taste leading to immediate attempts to spit it out. Treatment should consist of avoiding gastric lavage; whole egg mixed in milk can be given to neutralise chlorhexidine, but there is no specific antidote to cetrimide. Four affected babies were given hydrocortisone and ampicillin sodium intramuscularly, and two who were irritable were given intramuscular phenobarbitone.
It is likely that the babies' symptoms were mainly due to the caustic action of cetrimide 1%2 3; fortunately contact with the mixture was necessarily very brief as it is irritant with an unpleasant taste leading to immediate attempts to spit it out. Treatment should consist of avoiding gastric lavage; whole egg mixed in milk can be given to neutralise chlorhexidine, but there is no specific antidote to cetrimide. Four affected babies were given hydrocortisone and ampicillin sodium intramuscularly, and two who were irritable were given intramuscular phenobarbitone. If the absolute values of intake, output, and enzyme dose are not included it is impossible to confirm that these patients were receiving too small a dose of enzymes to control their malabsorption at the start of the study as appears to be the case.
It would be unfortunate if physicians responsible for patients with cystic fibrosis were to add misoprostol rather than treating their patients' malabsorption correctly-that is, increasing the dose of modern pancreatic microsphere preparation until symptoms are controlled, then checking the faecal fat output and intake. If the fat absorption is less than 90% the dose of enzyme should be increased and the process repeated. The manufacturer's literature is misleading as many patients require 6-10 capsules per meal of the microsphere preparations available in the United Kingdom. It We thank Drs Littlewood and Kelleher for their comments but it would appear that they have missed the main point of our paper, and as such our suggested role for misoprostol in the care of patients with cystic fibrosis. The idea that a patient with cystic fibrosis who does not have normal fat
